QLS32015
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QLS32015, covering 2025-09-22 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma [Phase 3]